Chemokines: Roles in leukocyte development, trafficking, and effector function

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 6, 2003, Pages 1185-1199

  Ono, Santa Jeremy ^a,b   Nakamura, Takao ^a   Miyazaki, Dai ^a   Ohbayashi, Masaharu ^a   Dawson, Maria ^a   Toda, Masako ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Allergy; Asthma; Chemokines; Receptors; Signal transduction

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; ALPHA CHEMOKINE; BERTILIMUMAB; BETA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR6; CX3C CHEMOKINE; IMMUNOLOGIC AGENT; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; NEUTRALIZING ANTIBODY; OLIGODEOXYNUCLEOTIDE DERIVATIVE; RANTES; RECEPTOR SUBTYPE; THROMBOCYTE FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE PHASE RESPONSE; ALLERGIC REACTION; CELL MATURATION; CELL MOTION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG TARGETING; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MAST CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0038518180     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1594     Document Type: Review

References (134)

1. Von Herrath MG, Harrison LC. Regulatory lymphocytes: antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003;3:223-32.
2. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001;20:705-32.
3. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003;111:215-25
4. Flower RJ. The development of COX2 inhibitors. Nat Rev Drug Discovery 2003;2:179-91.
5. Schultz A, Stuck BA, Feuring M, Hormann K, Wehling M. Novel approaches in the treatment of allergic rhinitis. Curr Opin Allergy Clin Immunol 2003;3:21-7.
6. Furue M, Terao H, Rikihisa W, Urabe K, Kinukawa N, Nose Y, et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol 2003;148:128-33.
7. Wolpe SD, Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 1989;3:2565-73.
8. D'Ambrosio D, Panina-Bordignon P, Sinigaglia F. Chemokine receptors in inflammation: an overview. J Immunol Methods 2003;273:3-13.
9. Root AW, Root MJ. Clinical pharmacology of human growth hormone and its secretagogues. Curr Drug Targets Immune Endocr Metabol Disord 2002;2:27-52.
10. Wong MM, Fish EN. Chemokines: attractive mediators of the immune response. Semin Immunol 2003;15:5-14.
11. Campbell JD, Stinson MJ, Simons FE, HayGlass KT. Systemic chemokine and chemokine receptor responses are divergent in allergic versus non-allergic humans. Int Immunol 2002;14:1255-62.
12. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 2003;111:227-42.
13. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003;111(suppl 2):460-75.
14. Gordon S. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 2003;3:36-50.
15. Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, Brett TJ. et al. Structural basis of chemokine sequestration by a herpes virus decoy receptor. Cell 2002;111:343-56.
16. Janeway CA, Ytavers P, Walport M, Shlomchik M. Immunobiology 5: the immune system in health and disease. New York: Garland; 2002.
17. Langenkamp A, Nagata K, Murphy K, Wu L, Lanzavecchia A, Sallusto F. Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells. Eur J Immunol 2003;33:474-82.
18. Price KS, Friend DS, Mellor EA, De Jesus N, Watts GF, Boyce JA. CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13. Am J Respir Cell Mol Biol 2003;28:420-7.
19. Lang K, Hatt H, Niggemann B, Zaenker KS, Entschladen F. A novel function for chemokines: downregulation of neutrophil migration. Scand J Immunol 2003;57:350-61.
20. Mariani M, Panina-Bordignon P. Analysis of homing receptor expression on infiltrating leukocytes in disease states. J Immunol Methods 2003;273:103-14.
21. Wuyts A, Struyf S, Gijsbers K, Schutyser E, Put W, Conings R, et al. The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with CXCL8/CXCL8. Lab Invest 2003;83:23-34.
22. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 2003;107:1009-16.
23. Mancardi S, Vecile E, Dusetti N, Calvo E, Stanta G, Burrone OR, et al. Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 2003;108:523-30.
24. Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8(+) T cells. J Exp Med 2003;197:643-56.
25. Coward WR, Okayama Y, Sagara H, Wilson SJ, Holgate ST, Church MK. NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells? J Immunol 2002;169:5287-93.
26. Woo CH, Jeong DT, Yoon SB, Kim KS, Chung IY, Saeki T, et al. Eotaxin induces migration of RBL-2H3 mast cells via a Rac-ERK-dependent pathway. Biochem Biophys Res Commun 2002;298:392-7.
27. Juremalm M, Hjertson M, Olsson N, Harvima I, Nilsson K, Nilsson G. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol 2000;30:3614-22.
28. Carollo M, Hogaboam CM, Kunkel SL, Delaney S, Christie MI, Perretti M. Analysis of the temporal expression of chemokines and chemokine receptors during experimental granulomatous inflammation: role and expression of MIP-1alpha and CCL2. Br J Pharmacol 2001;134:1166-79.
29. Schuh JM, Blease K, Hogaboam CM. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J Immunol 2002;168:1447-56.
30. Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al-Garawi A, et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A 2002;99:1479-84.
31. Youn BS, Yu KY, Alkhatib G, Kwon BS. The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287. Biochem Biophys Res Commun 2001;281:627-33.
32. Han KH, Green SR, Tangirala RK, Tanaka S, Quehenberger O. Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling. J Biol Chem 1999;274:32055-62.
33. Fan J, Malik AB. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat Med 2003;9:315-21.
34. Nardelli B, Tiffany HL, Bong GW, Yourey PA, Morahan DK, Li Y, et al. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1. J Immunol. 1999;162:435-44.
35. Lepidi H, Zaffran Y, Ansaldi JL, Mege JL, Capo C. Morphological polarization of human polymorphonuclear leucocytes in response to three different chemoattractants: an effector response independent of calcium rise and tyrosine kinases. J Cell Sci 1995;108(suppl):1771-8.
36. Tenscher K, Metzner B, Schopf E, Norgauer J, Czech W. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 1996;88:3195-9.
37. Shimizu Y. Signal transduction events regulating integrin function and T cell migration: new functions and complexity. Immunol Res 2003;27:107-28.
38. Lawson MA, Maxfield FR. Ca(2+)- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 1995;377:75-9.
39. Vulcano M, Struyf S, Scapini P, Cassatella M, Bernasconi S, Bonecchi R, et al. Unique regulation of CCL18 production by maturing dendritic cells. J Immunol 2003;170:3843-9.
40. Proudfoot AE, Power CA, Rommel C, Wells TN. Strategies for chemokine antagonists as therapeutics. Semin Immunol 2003;15:57-65.
41. Rodriguez-Frade JM, Mellado M, Martinez-A C. Chemokine receptor dimerization: two are better than one. Trends Immunol 2001;22:612-7.
42. Monteclaro FS, Charo IF. The amino-terminal extracellular domain of the CCL2 receptor, but not the CCL5/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for CCL2 receptor activation. J Biol Chem 1996;271:19084-92.
43. Schier AF. Chemokine signaling: rules of attraction. Curr Biol 2003;13:R192-4.
44. Rochdi MD, Parent JL. Galpha q-coupled receptor internalization specifically induced by Galpha q signaling: regulation by EBP50. J Biol Chem 2003;278:17827-37.
45. Preobrazhensky AA, Dragan S, Kawano T, Gavrilin MA, Gulina IV, Chakravarty L, et al. Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region. J Immunol 2000;165:5295-303.
46. Okkenhaug K, Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 2003;3:317-30.
47. Fenard D, Lambeau G, Valentin E, Lefebvre JC, Lazdunski M, Doglio A. Secreted phospholipases A(2), a new class of HIV inhibitors that block virus entry into host cells. J Clin Invest 1999;104:611-8.
48. Suzuki Y, Rahman M, Mitsuya H. Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 2001;167:3064-73.
49. Curnock AP, Ward SG. Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signaling. J Immunol Methods 2003;273:29-41.
50. Toda M, Nakamura T, Richardson RM, Ono SJ. Costimulation with MIP-Ia and IgE antigen enhances degranulation but inhibits chemotaxis in RBL-2H3 cells expressing human CCR1 [abstract]. J Allergy Clin Immunol 2003;111:S117.
51. Fukao T, Yamada T, Tanabe M, Terauchi Y, Ota T, Takayama T, et al. Selective loss of gastrointestinal mast cells and impaired immunity in P13K-deficient mice. Nat Immunol 2002;3:295-304.
52. Miyazaki D, Liu G, Clark L, Ono SJ. Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences. Invest Ophthalmol Vis Sci 2000;41:3850-5.
53. Lahn M, Kanehiro A, Takeda K, Terry J, Hahn YS, Aydintug MK, et al. MHC class I-dependent Vgamma4+ pulmonary T cells regulate alpha beta T cell-independent airway responsiveness. Proc Natl Acad Sci U S A 2002;99:8850-5.
54. Maguire JE, Danahey KM, Burkly LC, van Seventer GA. T cell receptor-and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells. J Exp Med 1995;182:2079-90.
55. Sakai T, Li S, Docheva D, Grashoff C, Sakai K, Kostka G, et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 2003;17:926-40.
56. Sachdev P, Zeng L, Wang LH. Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes. J Biol Chem 2002;277:17638-48.
57. Fernandis AZ, Cherla RP, Ganju RK. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45. J Biol Chem 2003;278:9536-43.
58. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976;58:408-20.
59. Dombrowicz D, Quatannens B, Papin JP, Capron A, Capron M. Expression of a functional Fc epsilon R1 on rat eosinophils and macrophages. J Immunol 2000;165:1266-71.
60. Ono SJ. Vernal keratoconjunctivitis: evidence for immunoglobulin E-dependent and immunoglobulin E-independent eosinophilia. Clin Exp Allergy 2003;33:279-81.
61. Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, et al. Transcriptional response of human mast cells stimulated via the FceR1 and identification of mast cells as a source of IL-11. BMC Immunol 2002;3:1-5.
62. Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M, Wells TN. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 2000;96:4046-54.
63. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003;111:450-63.
64. Lewis DB. Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? Curr Opin Immunol 2002;14:644-51.
65. Chapoval SP, Marietta EV, Smart MK, David CS. Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice. J Allergy Clin Immunol 2001;168:245-50.
66. Brown V, Warke TJ, Shields MD, Ennis M. T cell cytokine profiles in childhood asthma. Thorax 2003;58:311-6.
67. Parfrey NA, Prud'homme GJ, Colle E, Fuks A, Seemayer TA, Guttmann RD, et al. Immunologic and genetic studies of diabetes in the BB rat. Crit Rev Immunol 1989;9:45-65.
68. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-34.
69. Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez-A C, Coyle AJ, et al. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000;191:265-74.
70. Kim Y, Sung SS, Kuziel WA, Feldman S, Fu SM, Rose CE Jr. Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2). J Immunol 2001;166:5183-92.
71. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005-7.
72. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998;161:547-51.
73. Hirata H, Arima M, Cheng G, Honda K, Fukushima F, Yoshida N, et al. Production of CCL17 and CCL22 by naive T cells in asthmatic patients. J Clin Immunol 2003;23:34-45.
74. Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M, et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001;166:2055-62.
75. Ochi H, Hirani WM, Yuan Q, Friend DS, Auslen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 1999;190:267-80.
76. Trautmann A, Toksoy A, Engelhardt E, Brocker EB, Gillitzer R. Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. J Pathol 2000;190:100-6.
77. Lippert U, Artuc M, Grutzkau A, Moller A, Kenderessy-Szabo A, Schadendoff D, et al. Expression and functional activity of the CXCL8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol 1998;161:2600-8.
78. Ohkubo K, Ikeda M, Pawankar R, Gotoh M, Yagi T, Okuda M. Mechanisms of IL-6, CXCL8, and GM-CSF release in nasal secretions of allergic patients after nasal challenge. Rhinology 1998;36:156-61.
79. Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc Natl Acad Sci U S A 2000;97:6681-6.
80. Humbles AA, Lu B, Friend DS, Okinaga S, Lora J, Al-Garawi A, et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A 2002;99:1479-84.
81. Rothenberg ME, Eosinophilia. N Engl J Med 1998;338:1592-600.
82. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-63.
83. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. CCL5 and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:1489-95.
84. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D. Levitsky H. The central role of CD4(+) T cells in the antitumor immune response. J Exp Med 1998;188:2357-68.
85. Bertrand CP, Ponath PD. CCR3 blockade as a new therapy for asthma. Expert Opin Investig Drugs 2000;9:43-52.
86. Makino Y, Cook DN, Smithies O, Hwang OY, Neilson EG, Turka LA, et al. Impaired T cell function in CCL5-deficient mice. Clin Immunol 2002;102:302-9.
87. Ma W, Bryce PJ, Humbles AA, Laouini D, Yalcindag A, Alenius H, et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 2002;109:621-8.
88. Pinco KA, He W, Yang JT. alpha4beta1 integrin regulates lamellipodia protrusion via a focal complex/focal adhesion-independent mechanism. Mol Biol Cell 2002;13:3203-17.
89. Gomez-Mouton C, Abad JL, Mira E, Lacalle RA, Gallardo E, Jimenez-Baranda S, et al. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci U S A 2001;98:9642-7.
90. Salazar-Mather TP, Lewis CA, Biron CA, Type 1 interferons regulate inflammatory cell trafficking and macrophage inflammatory protein lalpha delivery to the liver. J Clin Invest 2002;110:321-30.
91. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;111:187-96.
92. Shapiro SD. Immunology: mobilizing the army. Nature 2003;421:223-4.
93. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002;2:773-86.
94. Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, et al. Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11. BMC Immunol 2002;3:5.
95. Liu ZJ, Haleem-Smith H, Chen H, Metzger H. Unexpected signals in a system subject to kinetic proofreading. Proc Natl Acad Sci U S A 2001;98:7289-94.
96. Oliveira SH, Lukacs NW. Stem cell factor and IgE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. Inflamm Res 2001;50:168-74.
97. Yano K, Yamaguchi M, de Mora F, Lantz CS, Butterfield JH, Costa JJ, et al. Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab Invest 1997;77:185-93.
98. Nakajima T, Inagaki N, Tanaka H, Tanaka A, Yoshikawa M, Tamari M, et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison. Blood 2002;100:3861-8.
99. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 1989;7:59-76.
100. Huang C, Friend DS, Qiu WT, Wong GW, Morales G, Hunt J, et al. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J Immunol 1998;160:1910-9.
101. Huang C, Wong GW, Ghildyal N, Gurish MF, Sali A, Matsumoto R, et al. The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma. J Biol Chem 1997;272:31885-93.
102. Ghildyal N, Friend DS, Stevens RL, Austen KF, Huang C, Penrose JF, et al. Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood. J Exp Med 1996;184:1061-73.
103. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-7.
104. Oliveira SH, Lukacs NW. Stem cell factor and IgE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. Inflamm Res 2001;50:168-74.
105. Price KS, Friend DS, Mellor EA, De Jesus N, Watts GF, Boyce JA. CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13. Am J Respir Cell Mol Biol 2003;28:420-7.
106. Inamura H, Kurosawa M, Okano A, Kayaba H, Majima M. Expression of the CXCL8 receptors CXCR1 and CXCR2 on cord-blood-derived cultured human mast cells. Int Arch Allergy Immunol 2002;128:142-50.
107. Gurish MF, Humbles A, Tao H, Finkelstein S, Boyce JA, Gerard C, et al. CCR3 is required for tissue eosinophilia and larval cytotoxicity after infection with Trichinella spiralis. J Immunol 2002;168:5730-6.
108. Cosmi L, Annunziato F, Maggi E, Romagnani S, Manetti R. Chemoattractant receptors expressed on type 2 T cells and their role in disease. Int Arch Allergy Immunol 2001;125:273-9.
109. Marone G, de Paulis A, Florio G, Petraroli A, Rossi FW, Triggiani M. Are mast cells MASTers in HIV-1 infection? Int Arch Allergy Immunol 2001;125:89-95.
110. Li Y, Li L, Wadley R, Reddel SW, Qi JC, Archis C, et al. Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood 2001;97:3484-90.
111. de Paulis A, De Palma R, Di Gioia L, Carfora M, Prevete N, Tosi G, et al. Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells. J Immunol 2000;165:7171-9.
112. Romagnani P, De Paulis A, Beltrame C, Annunziato F, Dente V, Maggi E, et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 1999;155:1195-204.
113. Beil WJ, Schulz M, Wefelmeyer U. Mast cell granule composition and tissue location - a close correlation. Histol Histopathol 2000;15:937-46.
114. Miyazaki D, Keane-Myers A, Cheung-Chau K-W, Chau KY, Ono SJ. The roles of chemokines in the development of murine allergic conjunctivitis. Invest Ophthalmol Vis Sci 1999;40:S687.
115. Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 2002;169:2712-8.
116. Ying, S, Meng Q, Barata LT, Kay AB. Macrophage inflammatory protein-1alpha and C-C chemokine receptor-1 in allergen-induced skin latephase reactions: relationship to macrophages, neutrophils, basophils, eosinophils and T lymphocytes. Clin Exp Allergy 2001;31:1724-31.
117. Wakahara S, Fujii Y, Nakao T, et al. Gene expression profiles for Fc epsilon RI, cytokines and chemokines upon Fc epsilon RI activation in human cultured mast cells derived from peripheral blood. Cytokine 2001;16:143-52.
118. Juremalm M, Olsson N, Nilsson G. Selective CCL5/CCL5-induced mast cell migration through interactions with chemokine receptors CCRI and CCR4. Biochem Biophys Res Commun 2001;50:168-74.
119. Bayce JA. Mast cells: beyond IgE. J Allergy Clin Immunol 2003;111:24-32.
120. Ono SJ. Vernal keratoconjunctivitis: evidence for immunoglobulin E-dependent and immunoglobulin E-independent eosinophilia. Clin Exp Allergy 2003;33:279-81.
121. Khan IA, Murphy PM, Casciotti L, Schwartzman JD, Collins J, Gao JL, et al. Mice lacking the chemokine receptor CCR 1 show increased susceptibility to Toxoplasma gondii infection. J Immunol 2001;166:1930-7.
122. Osbourn JK, Earnshaw JC, Johnson KS, Parmentier M, Timmermans V, McCafferty J. Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody library. Nat Biotechnol 1998;16:778-81.
123. Handy RLC, May RD, Main S, Vaughan TJ, Anderson IK. In vitro and in vivo effects of CAT-213, a human anti-eotaxin monoclonal antibody. Proc Int Symp Ocul Immunol Inflamm Transplant 2002:18
124. Miyazaki D, Liu G, Clark L, Ono SJ. Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences. Invest Ophthalmol Vis Sci 2000;41:3850-5.
125. Agrawal L, Alkhatib G, Agrawal L. The therapeutic potential of CXCR4 antagonists in the treatment of HIV. Expert Opin Investig Drugs 2003;12:185-95.
126. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 2003;3:36-50.
127. Barnes PJ. Potential novel therapies for chronic obstructive pulmonary disease. Novartis Found Symp 2001;234:255-72.
128. Guo J, Van Eck M, Twisk J, Maeda N, Benson GM, Groot PH, et al. Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis. Arterioscler Thromb Vasc Biol 2003;23:447-53.
129. Anders HJ, Vielhauer V, Frink M, Linde Y, Cohen CD, Blattner SM, et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 2002;109:251-9.
130. Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A 1999;96:6873-8.
131. Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003;111:333-40.
132. Toda M, Ono SJ. Genomics and proteomics of allergic disease. Immunology 2002;106:1-10.
133. Ono SJ. Molecular genetics of allergic diseases. Annu Rev Immunol 2000;18:347-66.
134. Senechal S, Fahy O, Gentina T, Vorng H, Capron M, Walls AF, et al. CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients. Lab Invest 2002;82:929-39.